FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma

Brain Tumor Pathology

Volumn 24, Issue 1, 2007, Pages 1-5

  Nagasaka, Toru ^a   Gunji, Masaharu ^a   Hosokai, Noboru ^b   Hayashi, Kumiko ^b   Ikeda, Hiroshi ^a   Ito, Masafumi ^a   Inao, Suguru ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

1p 19q imbalance; CDKN2A deletion; Fluorescence in situ hybridization; Glioblastoma; Oligodendroglioma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN;

ARTICLE; ASTROCYTOMA; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; OLIGODENDROGLIA; OLIGODENDROGLIOMA;

BRAIN NEOPLASMS; CHROMOSOME DELETION; GENE AMPLIFICATION; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34249658526     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-006-0209-6     Document Type: Article

References (14)

1. Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours of the nervous system. WHO/IARC, Lyon, France, pp 29-39
2. JA Kraus K Lamszus N Glesmann 2001 Molecular genetic alterations in glioblastomas with oligodendroglial component Acta Neuropathol (Berl) 101 311 320
3. B Donahue CB Scott JS Nelson 1997 Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02 Int J Radiat Oncol Biol Phys 38 911 914
4. JS Nelson CK Petito CB Scott 1996 Glioblastoma with oligodendroglial features (GBM-OL): report from Radiation Therapy Oncology Group (RTOG) trial 8302 Lab Invest 74 141A
5. J He K Mokhtari M Sanson 2001 Glioblastomas with an oligodendroglial component: a pathological and molecular study J Neuropathol Exp Neurol 60 863 871
6. MC Schmidt S Antweiler N Urban 2002 Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 321 328
7. C Decaestecker I Camby L Gordower 1998 Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-associated microscopy J Neuropathol Exp Neurol 57 791 802
8. SH Bigner MR Matthews BK Rasheed 1999 Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization Am J Pathol 155 375 386
9. PF Ambros IM Ambros 2001 SIOP Europe Neuroblastoma Pathology, Biology, and Bone Marrow Group: pathology and biopsy guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines Med Pediatr Oncol 37 40 50
10. F Cappuzzo FR Hirsch E Rossi 2005 Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 643 655
11. FR Hirsch M Varella-Garcia J McCoy 2005 Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study J Clin Oncol 23 6838 6845
12. C Stock IM Ambros G Mann 1993 Detection of Ip36 deletions in paraffin sections of neuroblastoma tissues Genes Chromosomes Cancer 6 1 9
13. E Gelpi IM Ambros P Birner 2003 Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens Mod Pathol 16 708 715
14. JG Cairncross K Ueki MC Zlatescu 1998 Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1473 1479